[Categories and characteristics of BPH drug evaluation models: a comparative study].

Huang, Dong-Yan; Wu, Jian-Hui; Sun, Zu-Yue

Huang, Dong-Yan; Wu, Jian-Hui; Sun, Zu-Yue.

Affiliation

Huang DY; Pharmacy School of Fudan University, Shanghai 201203, China. hdy043@163.com
Wu JH; Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, National Evaluation Center for Toxicology of Fertility Regulation Drugs, Shanghai 200032, China.
Sun ZY; Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, National Evaluation Center for Toxicology of Fertility Regulation Drugs, Shanghai 200032, China.

Zhonghua Nan Ke Xue ; 20(2): 181-5, 2014 Feb.

Article in Zh | MEDLINE | ID: mdl-24520675

Subject(s)

Drug Design; Drug Evaluation; Animals; Disease Models, Animal; Male; Prostatic Hyperplasia/drug therapy

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Drug Design / Drug Evaluation Type of study: Prognostic_studies Limits: Animals Language: Zh Journal: Zhonghua Nan Ke Xue Journal subject: MEDICINA REPRODUTIVA Year: 2014 Type: Article Affiliation country: China

Search on Google

XML

PubMed Links